I-23456: Immunotherapy response in non-small cell lung cancer Under review
Dr. Marcus Oyelaran, Thoracic Oncology. IRB protocol IRB-2026-0388.
Approved scope
Cohort
Lung cancer (ICD-10 C34)
Variables
Diagnoses, medications, labs, encounters
Date range
2015-01-01 to 2026-06-30
Identifiers released
None (de-identified)
Data use
Retrospective cohort study
Retention
24 months, then disposition
Honest broker
J. Whitcomb
Workspace
research-I23456 (export disabled, onward sharing blocked)
Approval trail
- Submitted by Dr. Marcus Oyelaran (Principal investigator)
2026-10-09 10:02
Request submitted with IRB protocol IRB-2026-0388. - Review started by J. Whitcomb (Honest broker)
2026-10-12 15:40
Feasibility count requested; minimum necessary review of variables.
Audit trail for I-23456
No access events for this protocol yet.